RONZONI, FLAVIO LORENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.095
EU - Europa 751
AS - Asia 481
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 4
AF - Africa 2
Totale 2.344
Nazione #
US - Stati Uniti d'America 1.090
CN - Cina 431
IE - Irlanda 279
FI - Finlandia 96
UA - Ucraina 90
IT - Italia 88
DE - Germania 77
SE - Svezia 44
SG - Singapore 41
GB - Regno Unito 29
BE - Belgio 26
FR - Francia 11
AU - Australia 7
CA - Canada 5
EU - Europa 4
CZ - Repubblica Ceca 3
NL - Olanda 3
BD - Bangladesh 2
BR - Brasile 2
CH - Svizzera 2
IN - India 2
AR - Argentina 1
AT - Austria 1
CL - Cile 1
GR - Grecia 1
IR - Iran 1
JP - Giappone 1
KZ - Kazakistan 1
MA - Marocco 1
QA - Qatar 1
RO - Romania 1
TH - Thailandia 1
ZA - Sudafrica 1
Totale 2.344
Città #
Dublin 278
Chandler 247
Jacksonville 127
Nanjing 123
Ashburn 105
Ann Arbor 67
Boardman 63
Nanchang 55
Helsinki 45
Beijing 43
Princeton 43
Lawrence 42
Medford 41
Wilmington 34
Hebei 33
Shenyang 31
Jiaxing 30
Changsha 29
Milan 28
Singapore 28
Shanghai 27
Hangzhou 22
Brussels 21
Pavia 17
Woodbridge 15
Tianjin 13
Verona 10
Redwood City 8
Dearborn 7
Fairfield 7
Washington 7
New York 6
San Francisco 6
Norwalk 5
Auburn Hills 4
Los Angeles 4
Munich 4
Seattle 4
Toronto 4
Brno 3
Chicago 3
Herent 3
Houston 3
Jinan 3
Cicciano 2
Des Moines 2
Frankfurt am Main 2
Gunzenhausen 2
Lausanne 2
Leuven 2
Ningbo 2
Rome 2
Zhengzhou 2
Athens 1
Bitonto 1
Bologna 1
Canberra 1
Cheyenne 1
Dallas 1
Doha 1
Fuzhou 1
Groningen 1
Hefei 1
Kunming 1
Lanzhou 1
Lincoln 1
Mainz 1
Maynooth 1
Melbourne 1
Monmouth Junction 1
Muizenberg 1
Nova Milanese 1
Orange 1
Palermo 1
Pune 1
Redmond 1
Rockville 1
Rozzano 1
Saint Louis 1
Shijiazhuang 1
Surat Thani 1
Taiyuan 1
Tokyo 1
Udine 1
Varese 1
Vienna 1
Xi'an 1
Totale 1.750
Nome #
Characterization Of Cardiac Progenitors From Murine Dystrophic Heart. 103
Alpha sarcoglycan is required for FGF dependent myogenic progenitor cell proliferation in vitro and in vivo. 99
In vitro adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 95
Improved adhesion and bone differentiation of Human Mesenchymal Stem Cells (hMSCs) and Human Dental Pulp Stem Cells (hDPSCs) on positively charged surfaces 93
GENE EXPRESSION PROFILE IN MAGIC-F1 MYOGENIC PROGENITORS 88
Behaviour of human mesenchymal-periosteal cells grown in contact with different scaffolds used in dentistry 77
Magic Factor-1, a partial agonist of Met, induces muscle hypertrophy by protecting myogenic progenitors from apoptosis 72
Gene signature of muscle hypertrophy 66
Cardiac dystrophic mesoangioblasts molecular characterization of in vitro and in vivo differentiation. 66
Cellular mechanisms and local progenitor activation to regulate skeletal muscle mass. 64
Met-Activating Genetically Improved Chimeric Factor-1 Promotes Angiogenesis and Hypertrophy in Adult Myogenesis 63
Stem cell therapy in muscular dystrophiesStem cell and small RNAs as tools for basic science and regenerative medicine 62
Magic Factor-1: a new engineered protein involved in muscular hypertrophy and regeneration 61
Skeletal muscle engineering: scaffolds and recombinant proteins 61
Stem Cell homing and regulation: new insights from muscular dystrophy 60
HGF-DERIVED RECOMBINANT PROTEIN M.A.G.I.C. F1: A NOVEL APPROACH TO INDUCE MUSCULAR HYPERTROPHY 58
HGF-derived recombinant protein M.A.G.I.C F1: a novel approach to induce muscular hypertrophy 58
Muscle hypertrophy and vascularization induction using recombinant proteins 58
Cardiac dystrphic mesoangioblasts: Molecular characterization of in vitro and in vivo differentiation 56
Magic F1 hypertropic factor to enhance myogenesis on polyesterurethane scaffolds 56
The effects of micro-grafts in the treatment of androgenetic alopecia 54
Recombinant proteins and PCL biomaterial to burst myogenesis in vitro 52
Analysis of isometric strength and force-velocity relationship after 7 weeks of stable and unstable training on partial push up 52
Terapia cellulare mesenchimale nella distrofia muscolare 51
In vitro and in vivo tissue engineering approaches in regenerative medicine 51
Autologous micrograft accelerates endogenous wound healing response through ERK-induced cell migration 51
Magic F-1: a new engineered protein involved in muscular hypertrophy and regeneration 50
Cardiac development and remodelling in Magic-F1 transgenic mice 49
Magic-F1 transgene cooperates with Pax 3 during early myogenesis to induce muscular hypertrophy 48
Colonization properties of different collagen sponges in skin repair 48
In vitro and in vivo studies of alar-nasal cartilage using autologous micro-grafts: The use of the Rigenera® protocol in the treatment of an osteochondral lesion of the nose 46
Skeletal muscle regenerative approach combining stem cells and 3D bioprinting 46
Molecular signature of amniotic fluid derived stem cells in the fetal sheep model of myelomeningocele 45
Myoblast 3D bioprinting to burst in vitro skeletal muscle differentiation 45
In vitro osteoblastic differentiation of human mesenchymal stem cells and human dental pulp stem cells on poly-L-lysine-treated titanium-6-aluminium-4-vanadium 44
Magic F1, a dimerized c-met binding domain, induces muscle hypertrophy by protecting from apoptosis myogenic progenitors 43
Inducing muscular hypertrophy by recombinant proteins 40
Why to open an Institute of Anatomy to the public: opportunities for socially useful interactions. 35
Myogenic induction of adult and pluripotent stem cells using recombinant proteins 34
The investigation of the effects of autologous micrografts in the process of wound healing 32
Human fetal mesoangioblasts reveal tissue-dependent transcriptional signatures 29
Guide cells support muscle regeneration and affect neuro-muscular junction organization 28
Totale 2.389
Categoria #
all - tutte 9.624
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.624


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020134 0 0 0 0 0 24 10 23 18 40 19 0
2020/2021218 22 15 7 21 4 25 10 41 9 31 25 8
2021/2022192 6 4 2 2 3 1 5 9 11 5 31 113
2022/2023751 99 63 13 44 68 59 1 55 319 6 21 3
2023/2024263 54 33 17 19 29 55 6 13 2 4 9 22
2024/2025141 12 58 37 19 14 1 0 0 0 0 0 0
Totale 2.389